Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
- Citation:
- J Clin Oncol vol 25 (23) 3456-61
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- 2 U10 CA33601-25
- Corr. Author:
- Authors:
- Leonard B Saltz Donna Niedzwiecki Donna Hollis Richard M Goldberg Alexander Hantel James P Thomas Anthony L A Fields Robert J Mayer
- Networks:
- Study
- Alliance-89803
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords:
- Adult, Aged, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms, Disease-Free Survival, Female, Fluorouracil, Humans, Leucovorin, Male, Middle Aged, Neoplasm Metastasis, Prognosis, Treatment Outcome